Aquestive Therapeutics, Inc.AQSTNASDAQ
Loading
Revenue ContractionContracting
Percentile Rank0
3Y CAGR-2.2%
5Y CAGR-0.6%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
-2.2%/yr
vs -8.3%/yr prior
5Y CAGR
-0.6%/yr
Consistent
Acceleration
+6.1pp
Accelerating
Percentile
P0
Near historical low
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$44.55M-22.6%
2024$57.56M+13.8%
2023$50.58M+6.1%
2022$47.68M-6.2%
2021$50.83M+10.9%
2020$45.85M-12.8%
2019$52.61M-22.0%
2018$67.43M+0.8%
2017$66.92M+29.2%
2016$51.78M-